PRESS RELEASE published on 11/09/2023 at 07:29, 1 year 4 months ago Fielmann Group benefits from position as price leader, continues double-digit growth
PRESS RELEASE published on 09/01/2023 at 07:29, 1 year 7 months ago Fielmann Group AG: Fielmann Group closes US acquisition of SVS Vision, upgrades FY2023 prognosis
PRESS RELEASE published on 08/24/2023 at 07:30, 1 year 7 months ago Fielmann Group AG:Fielmann Group confirms double-digit growth in HY1/2023
PRESS RELEASE published on 07/13/2023 at 07:28, 1 year 8 months ago Fielmann Group expects HY1/2023 sales to grow +13%, EBITDA +21% over last year
PRESS RELEASE published on 06/07/2023 at 15:56, 1 year 9 months ago Optical retailer Fielmann Group enters US market, acquires SVS Vision and Befitting
PRESS RELEASE published on 06/07/2023 at 15:53, 1 year 9 months ago EQS-Adhoc: Fielmann AG: Optical retailer Fielmann Group enters US market, acquires SVS Vision and Befitting
PRESS RELEASE published on 04/27/2023 at 07:30, 1 year 11 months ago Fielmann AG: Quarterly Report and Press Release as of 31 March 2023
PRESS RELEASE published on 02/23/2023 at 07:37, 2 years 1 month ago EQS-Adhoc: Fielmann AG: Preliminary Figures for FY2022/Dividend
Published on 04/07/2025 at 14:30, 27 minutes ago Newsmax Enters into Standby Equity Purchase Agreement of Up to $1.2 Billion With Yorkville Advisors
Published on 04/07/2025 at 14:30, 27 minutes ago Sparta Provides Update on Delay in Filing Annual Financial Statements
Published on 04/07/2025 at 14:00, 57 minutes ago NOA Lithium Advances Towards 2025 Water Exploration at Rio Grande Project
Published on 04/07/2025 at 14:00, 57 minutes ago Rio Grande Resources Announces the Successful Completion of Sampling and Field Campaign at the Winston Gold-Silver Project
Published on 04/07/2025 at 14:00, 57 minutes ago Tharimmune Announces Positive Data with Novel Biparatopic PD-1/VEGF and Multispecific HER2/HER3 Biologics Leveraging Proprietary EpiClick(TM) Technology
Published on 04/07/2025 at 14:24, 32 minutes ago OTRS AG: Voluntary Public Tender Offer of Optimus BidCo AG
Published on 04/07/2025 at 13:00, 1 hour 57 minutes ago CureVac Receives U.S. FDA IND Clearance to Initiate Phase 1 Clinical Trial for Novel mRNA-Based Precision Immunotherapy in Squamous Non-Small Cell Lung Cancer
Published on 04/07/2025 at 12:57, 2 hours ago PFISTERER acquires long-standing partner Power CSL - portfolio expanded to include subsea solutions
Published on 04/07/2025 at 11:57, 2 hours 59 minutes ago Share buyback: Announcement pursuant to Article 5 (1) (b) and (3) of Regulation (EU) No. 596/2014
Published on 04/07/2025 at 07:01, 7 hours 56 minutes ago bioMérieux obtient le marquage CE pour LUMED™ APSS™, une solution logicielle de pointe pour aider à prendre des décisions en matière de bon usage des antibiotiques
Published on 04/07/2025 at 07:01, 7 hours 56 minutes ago bioMérieux obtains CE-marking for LUMED™ APSS™, a cutting-edge software solution to aid medical decision-making in Antimicrobial Stewardship
Published on 04/04/2025 at 19:18, 2 days 19 hours ago Mersen: Number of shares and voting rights as of March 31, 2025
Published on 04/04/2025 at 19:18, 2 days 19 hours ago Mersen : nombre d'actions et de droits de vote au 31 mars 2025
Published on 04/04/2025 at 18:17, 2 days 20 hours ago Reporting on share buyback transactions carried out between March 31 and April 3, 2025
